Leveraging cancer metabolism to translate into effective therapeutics.
Abnormal metabolism is a typical characteristic of malignant tumors, broadly influencing the outcome of cancer therapy.
APA
Xu J, Guo L, et al. (2026). Leveraging cancer metabolism to translate into effective therapeutics.. Seminars in cancer biology, 118, 44-61. https://doi.org/10.1016/j.semcancer.2025.12.003
MLA
Xu J, et al.. "Leveraging cancer metabolism to translate into effective therapeutics.." Seminars in cancer biology, vol. 118, 2026, pp. 44-61.
PMID
41390072
Abstract
Abnormal metabolism is a typical characteristic of malignant tumors, broadly influencing the outcome of cancer therapy. Research on tumor metabolism has increased exponentially in last decades. There is an urgent need to provide a blueprint or framework to accelerate the translation of cancer metabolism research into effective therapeutics. In this review, we summarize the impact of metabolism on cancer progression and emerging metabolic therapies, and systematically outline potential clinical applications in cancer prevention, early screening, diagnosis, treatment, and new challenges. Furthermore, we aim to provide researchers and clinicians with a clearer perspective on the immediate translation of clinical applications stemming from cancer metabolism research. It will revolutionize cancer management and significantly enhance patient survival.
MeSH Terms
Humans; Neoplasms; Animals; Energy Metabolism; Translational Research, Biomedical
같은 제1저자의 인용 많은 논문 (5)
- CRISPR/Cas9 Screening Reveals that UBE2L3 Modulates Autophagic Flux through TSC2 Ubiquitination and Potentiates PD-1 Blockade in Triple-Negative Breast Cancer.
- The TRIM3/TLR3 axis overrides IFN-β feedback inhibition to suppress NSCLC progression.
- Tumor cell-intrinsic PD-1 in malignant ascites drives ovarian cancer progression via MAPK/ERK signaling.
- Molecular Imaging of Hepatocellular Carcinoma with Third-Generation US Contrast Agents: Toward Clinical Translation.
- Pulmonary sclerosing pneumocytoma with lymph node metastasis and high FDG uptake in PET/CT: a rare case report and literature review.